Herbal Formula Science (대한한의학방제학회지)

The Korean Medicine Society for the Herbal Formula Study (대한한의학방제학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report on the Treatment of Korean Medicine in Psoriasis Patients Who Have Deteriorated Since COVID-19 mRNA Vaccination

COVID-19 mRNA 백신 접종 이후 악화된 건선 환자의 한의 치료 증례보고

  • Yu Seok, Song (College of Korean Medicine, Woosuk University) ;
  • Sang Won, Byun (College of Korean Medicine, Woosuk University) ;
  • Si Woo, Lee (College of Korean Medicine, Woosuk University) ;
  • Dong Lim, Ha (Hadonglim Korean Medicine Clinic) ;
  • Jun Hyung, Kim (Sunchang Health Center and County Hospital) ;
  • Hong Jun, Kim (Department of Formula Science, College of Korean Medicine, Woosuk University) ;
  • Young Sik, Kim (Department of Herbology, College of Korean Medicine, Woosuk University)
  • 송유석 (우석대학교 한의과대학) ;
  • 변상원 (우석대학교 한의과대학) ;
  • 이시우 (우석대학교 한의과대학) ;
  • 하동림 (하동림한의원) ;
  • 김준형 (순창 보건의료원) ;
  • 김홍준 (우석대학교 한의과대학 방제학교실) ;
  • 김영식 (우석대학교 한의과대학 본초학교실)
  • Received : 2022.11.02
  • Accepted : 2022.11.11
  • Published : 2022.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The purpose of this study is to report one case of Korean medical treatment on a patient with psoriasis which had deteriorated since COVID-19 mRNA vaccination. Methods : A patient with psoriasis was treated with herbal medicine, acupuncture, and moxibustion. Symptoms after vaccination were considered the main criteria for treatment. PASI, DLQI, VAS, and pictures were used as evaluation tools for psoriasis. Results : After treatment, the patient showed improvements in PASI, DLQI and VAS scores. PASI changed from 16 to 0, DLQI changed from 17 to 0, and VAS changed from 8 to 0. Conclusions : The findings of this case report suggest that Korean medicine may be an effective option for treating psoriasis after COVID-19 mRNA vaccination.

Keywords

Acknowledgement

본 연구는 2022년도 우석대학교 교내 연구비 지원을 받아 수행되었음.

References

  1. Seo HS, Kim KS, Kwon K, Kim KJ, Kim JH, Park MC et al. Surgery & Dermatology of KOREAN MEDICINE, Vol2. Dermatology of Korean Medicine.1st ed.Paju, Gyeonggido:Globooks. 2022:86.
  2. Youn JI. Psoriasis in Korean. Korean J Dermatol 2012;50(5):387-402.
  3. Yang YH, Son SH, Cho AR, Park SJ. Retrospective Study about the Effectieness of orean Medical Treatment on 101 Psoriasis Patients for 6 months. J Korean Med Ophthalmol Otolaryngol Dermatol, 2017;30(4):142-152.
  4. Kim NK, Hwang CY, Lim GS. The oriental and occidental bibliographic study of psoriasis. J Korean Orient Ophthalmol Otorhinolaryngol Dermatol. 1999;12(1):154-78.
  5. Cho YS, Baek JH. A Review of Case Studies with Pattern Identifications and Herbal Medicines for Psoriasis. J Pediatr Korean Med, 2017;31(1):1-11. https://doi.org/10.7778/JPKM.2017.31.1.001
  6. European Medicines Agency (EMA). Safety of COVID-19 vaccines. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/safety-covid-19-vaccines.
  7. Cho MK, Kim DH. Psoriasis Exacerbation after Pfizer-BioNTech COVID-19 mRNA Vaccine. Journal of the Korean Society for Psoriasis. 2022;19(1): 27-29.
  8. Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, Attia S. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology (Basel). 2021;10(8):752.
  9. Bozek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851-856. https://doi.org/10.17219/acem/69804
  10. Kim NK, Lee DH, Jo GW, Moon H, Seo ES. A study on the correlation between quality of life and disease severity in adult patients with atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2011;24(3):27-36.
  11. Choi YH, Lee KH, Cho SI, Ko JI, Kim YJ, Choi YY, et al. BNT162b2 mRNA COVID-19 vaccine adverse reactions needing medical support: a vaccine center experience. J Korean Soc Emerg Med. 2022;33(2):164-171.
  12. Public Health and Medical Professionals for Transparency. 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021.
  13. Krajewski PK, Matusiak L, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol. 2021;35(10):e632-e634.
  14. Min DL, Chang SJ, Park EJ. A Case Report of Treating Childhood Psoriasis by Danguieumja-gagambang and External Treatments. J Korean Oriental Pediatrics. 2012;26(3):20-29.
  15. Han CY, Kim JD, Seo GY, Kim KS, Kim YB. Investigation of Effective Korean Herbal Medicine for Psoriasis -Focusing on Lipid Metabolism. J Korean Med Ophthalmol Otolaryngol Dermatol. 2021;34(3):70-79.
  16. Youn JI, Treatment of Psoriasis. J Korean Med Assoc. 2006;49(2):150-160. Korean.
  17. Lee SD, Jung SY, Lee SG. Comparison of Research Characteristics in Western, Chinese Traditional Medicine and Korean Medicine on Psoriasis. J Korean Med. 2021;42(2):72-81.
  18. Shin SS. Herbal Formula Science in Korean Medicine. 1st ed. Paju, Gyeonggido: KOONJA. 2020:623-630.
  19. Shanghai University of T.C.M : Traditional Chinese Medicine Surgery, Hong Kong: Commercial Press Hong Kong Branch. 1981:141-144.
  20. So WB. Treatise on the Pathogenesis and Manifestations of All Diseases. Seoul: Jeongdam. 1985:796-8.
  21. Shirai G. modern 「Yakjing」. J of KMediACS. 2011;3(1):147-149.
  22. Do DM. Surgical diagnosis and Treatment map of traditional Chinese medicine, Shanghai: Shanghai Traditional Chinese Medicine Publisher. 1993:54,55.
  23. Ju YS. Herbal medicine. 3rd ed. Seoul: younglimsa. 2004:396,661.